| 发明名称 |
The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders |
| 摘要 |
The disclosure relates to a use of 4-(acetylamino)-N-(2aminophenyl)benzamide (CI-994) or dinaline or a pharmaceutically acceptable salt, ester, prodrug or metabolite thereof in the manufacture of a medicament for the treatment of Alzheimer’s disease, Huntington’s disease, for improving cognitive function in a normal subject and for promoting fear extinction in a subject. |
| 申请公布号 |
NZ599757(A) |
申请公布日期 |
2014.08.29 |
| 申请号 |
NZ20100599757 |
申请日期 |
2010.10.29 |
| 申请人 |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY;THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL;THE BROAD INSTITUTE INC. |
发明人 |
GRAEFF JOHANNES;HAGGARTY STEPHEN J.;GUAN JI-SONG;HOLSON EDWARD;TSAI LI-HUEI;WAGNER FLORENCE |
| 分类号 |
A01N37/12;A61K31/195 |
主分类号 |
A01N37/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
